SuPAR identifies patients at high risk of blood clot formation

Blood clots are thought to occur in as many as a third of patients hospitalized with COVID-19. In many cases these clots can be deadly, such as pulmonary embolisms—blood clots that travel to the lungs. In fact, in nearly one third of patients with COVID-19, these clots led to death.

source https://medicalxpress.com/news/2022-08-supar-patients-high-blood-clot.html